In this chapter, the healthcare industry’s perspective on the benefits of collaborating with academia in designing, building, and testing prototypes is discussed. The term healthcare industry is very broad and, for the purposes of this chapter, is represented by manufacturers of commercial diagnostic and therapeutic medical imaging devices, such as optical imaging, magnetic resonance (MR) imaging, computed tomography (CT), positron emission tomography (PET), ultrasound (US), fluoroscopy, and x-ray imaging devices (x-ray) as well as the manufacturers of the complementary imaging biomarkers, such as 18-fluorodeoxyglucose (FDG) for PET. The term academia is defined to be universities, university and teaching hospitals, government laboratories, and government hospitals that perform research in the areas of medical science, biomedical engineering, imaging, and imaging biomarkers. Their research is typically funded by grants awarded by state and federal agencies (such as the NIH), private foundations, donations, and industry. While the main focus of this chapter is the collaboration between academia and industry on the topic of academic prototypes, the reader should keep in mind that the relationship between academics and industry is usually much broader.
Online access to SPIE eBooks is limited to subscribing institutions.